Status: current, Primitive. Date: 31-Jan 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4767651000168110 | anifrolumab (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4767661000168112 | anifrolumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| anifrolumab | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Saphnelo 300 mg/2 mL injection, 2 mL vial | has intended active ingredient | True | anifrolumab | Inferred relationship | Some | 1762303843 |
| Saphnelo 300 mg/2 mL injection, 2 mL vial | has Australian BoSS | True | anifrolumab | Inferred relationship | Some | 1762303843 |
| anifrolumab 300 mg/2 mL injection, vial | has Australian BoSS | True | anifrolumab | Inferred relationship | Some | 1271177837 |
| anifrolumab 300 mg/2 mL injection, vial | has intended active ingredient | True | anifrolumab | Inferred relationship | Some | 1271177837 |
| anifrolumab | has intended active ingredient | True | anifrolumab | Inferred relationship | Some | 1273099902 |
This concept is not in any reference sets
FHIR